Pamorelin 11

DRUG2 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Karolinska University Hospital

Conditions

Acute LeukemiaBreast CancerLymphomas (Hodgkin and non-Hodgkin) ans Sarcomas (OsteoSoft tissue and Ewing)low-volume metastatic castration-sensitive prostate cancer

Phase 3

Apa/Enza short study (Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-volume metastatic castration-sensitive prostate cancer: a randomized nationwide trial

RecruitingCTIS2023-506698-36-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)low-volume metastatic castration-sensitive prostate cancer

Start: 2024-02-02Target: 400Updated: 2025-12-03

A phase III Randomized Double-Blinded Placebo-Controlled Study of Use of GnRHa during Chemotherapy for Fertility Protection of Young Women and Teenagers with Cancer - ProFertil

Not yet recruitingCTIS2024-518977-32-00

Karolinska University HospitalAcute Leukemia, Breast Cancer, Lymphomas (Hodgkin and non-Hodgkin) ans Sarcomas (Osteo +1

Target: 500Updated: 2024-10-25